We are live on ! Find out more
EC

Euclidean Capital Portfolio holdings

AUM $392M
1-Year Est. Return 31.85%
This Fund
S&P 500
This Quarter Est. Return
-1.88%
1 Year Est. Return
+31.85%
3 Year Est. Return
+76.27%
5 Year Est. Return
-20.16%
10 Year Est. Return
–
AUM
$737M
AUM Growth
-$170M
Cap. Flow
-$154M
Cap. Flow %
-20.86%
Top 10 Hldgs %
100%
Holding
12
New
–
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$30.5M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$181M
2
ME
23andMe Holding Co
ME
+$3.59M

Sector Composition

Rank Sector Weight
1 Healthcare 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$795B
$525M 71.3%
896,254
-306,550
-25% -$181M
INDA icon
2
iShares MSCI India ETF
INDA
$6.89B
$128M 17.33%
2,425,144
– –
VEU icon
3
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$58.2M 7.9%
1,013,434
+505,834
+100% +$30.5M
ORIC icon
4
Oric Pharmaceuticals
ORIC
$1.15B
$7.98M 1.08%
989,410
– –
FHTX icon
5
Foghorn Therapeutics
FHTX
$266M
$7.43M 1.01%
1,573,761
– –
PMVP icon
6
PMV Pharmaceuticals
PMVP
$59.2M
$3.97M 0.54%
2,627,643
– –
ALEC icon
7
Alector
ALEC
$168M
$2.47M 0.34%
1,307,858
– –
TNYA icon
8
Tenaya Therapeutics
TNYA
$161M
$1.45M 0.2%
1,015,705
– –
SRZN icon
9
Surrozen
SRZN
$258M
$1.26M 0.17%
87,696
– –
RAPT
10
DELISTED
RAPT Therapeutics
RAPT
$1.04M 0.14%
82,237
– –
SRZNW icon
11
Surrozen Inc Warrant
SRZNW
$3.66K ﹤0.01%
170,833
– –
ME
12
DELISTED
23andMe Holding Co
ME
– –
-512,156
Closed -$3.59M

Similar funds

WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
RC
Riposte Capital New York $392M AUM 69.08% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $392M AUM 108.45% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
BWM
Buckley Wealth Management Las Vegas, Nevada $392M AUM 28.21% 1-Year Est. Return
IPW
Inlet Private Wealth Jupiter, Florida $392M AUM 25.74% 1-Year Est. Return
TCM
Turas Capital Management Boston, Massachusetts $392M AUM
MA
Mezzasalma Advisors Tinton Falls, New Jersey $391M AUM 40.85% 1-Year Est. Return

Euclidean Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Euclidean Capital held 12 positions worth $737M, down 19% from $907M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Euclidean Capital withdrew a net $154M in Q4 2024, closing 1 position and reducing 1 holding. Its most notable exit was 23andMe Holding Co, an estimated $3.59M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.7% a quarter earlier.

Against the trend, Euclidean Capital added an estimated $30.5M to Vanguard FTSE All-World ex-US ETF.

  • Euclidean Capital added most to Vanguard FTSE All-World ex-US ETF in Q4 2024, an estimated $30.5M increase.
  • Euclidean Capital's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $181M.
  • Euclidean Capital fully exited 23andMe Holding Co in Q4 2024, selling an estimated $3.59M.
  • Euclidean Capital's ten largest holdings make up 100% of its $737M portfolio in Q4 2024.
  • Euclidean Capital opened 0 new positions and closed 1 in Q4 2024.
  • Euclidean Capital's portfolio value fell 19% quarter-over-quarter to $737M.

Based on Euclidean Capital's 13F filing for Q4 2024, filed 14 Feb 2025.